Contribute Try STAT+ Today

In a searing rebuke, the Biden administration is formally withdrawing a last-minute proposal by the Trump administration to exempt a wide swath of medical devices and artificial intelligence tools from regulatory review.

Officials with Biden’s Health and Human Services Department and the federal Food and Drug Administration posted a document on the federal register indicating that they will not proceed with the proposed exemptions. The document sharply criticizes a lack of transparency by Trump officials and cites errors and badly flawed logic in proposing to relax scrutiny of some devices whose malfunctioning could result in serious harm or even death.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.